Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Neuropharmacology. 2013 May 17;73:19–30. doi: 10.1016/j.neuropharm.2013.05.001

Table 3.

Comparison of IC50 and Ki values (nM) for DHβE blockade of ACh-stimulated DA release

Genotype IC50 (nM)
α4β2-mediated
α-CtxMII-
resistant
using 3 µM ACh
IC50 (nM)
α4β2-mediated
α-CtxMII-
resistant
using 0.3 µM
ACh
IC50 (nM)
α6β2-mediated
α-CtxMII-
sensitive
using 3 µM ACh
IC50 (nM)
α6β2-mediated
α-CtxMII-
sensitive
using 0.3 µM
ACh
+/+ 60 ± 4 11 ± 1 1848 ± 848 238 ± 169
+/Leu9’Ala 95 ± 23 12 ± 4 1175 ± 358 180 ± 49
Leu9’Ala/Leu9’Ala 1175 ± 412 *+ 68 ± 12 *+ 714 ± 140 118 ± 35
Ki (nM)
α4β2-mediated
α-CtxMII-
resistant
using 3 µM ACh
Ki (nM)
α4β2-mediated
α-CtxMII-
resistant
using 0.3 µM
ACh
Ki (nM)
α6β2-mediated
α-CtxMII-
sensitive
using 3 µM ACh
Ki (nM)
α6β2-mediated
α-CtxMII-
sensitive
using 0.3 µM
ACh
+/+ 12 ± 1 8 ± 1 83 ± 38 77 ± 55
+/Leu9’Ala 9 ± 2 6 ± 2 42 ± 13 49 ± 13
Leu9Ala/Leu9Ala 31 ± 11 *+ 14 ± 3 *+ 53 ± 10 39 ± 12
*

significantly different from +/+.

+

significantly different from +/Leu9′Ala.

Notes: Data collected at 3 µM ACh from 5 WT, 4 HET, 2 HOM mice and at 0.3 uM ACh from 5 WT, 4 HET, 3 HOM mice. For each, 4–5 concentrations of DHβE were assayed, 0, 0.01, 0.1, 1, 10 µM with and without 50 nM αCtxMII. Data was curve fit from all individual points for each ACh concentration using the single exponential decay equation: f=a*exp(-b*x), where a=uninhibited release, b=decay constant and 0.693/b=IC50 value. The Ki values were calculated from the equation: Ki=IC50/(1+[ACh]/EC50) where EC50 values are taken from Table 1. By ANOVA, using all determinations of Ki, the resistant Ki for mutant is significantly different than WT.